<DOC>
	<DOC>NCT01252563</DOC>
	<brief_summary>In this survey, to collect the safety and efficacy information in the subjects who have been treated with amlodipine 5mg at least 4 weeks in daily practice.</brief_summary>
	<brief_title>Amlodipine 10mg Drug Use Investigation</brief_title>
	<detailed_description>All the subjects whom an investigator prescribes Amlodipine (Norvasc®) 10mg Tablet should be registered consecutively until the number of subjects reaches target number in order to extract patients enrolled into the investigation at random.</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Male or female subjects who have been treated with amlodipine 5mg at least 4 weeks The subjects who had not achieved target BP Subjects who have been prescribed amlodipine (Norvasc®) 10mg Tablet before</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>ENTER10</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Japanese</keyword>
	<keyword>Norvasc 10mg</keyword>
	<keyword>Post Marketing surveillance</keyword>
</DOC>